A new trading day began on Monday, with Enfusion Inc (NYSE: ENFN) stock price up 8.75% from the previous day of trading, before settling in for the closing price of $9.94. ENFN’s price has ranged from $7.52 to $11.38 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Technology Sector giant saw their annual sales surged by 31.47% over the last five years. Meanwhile, its annual earnings per share averaged 62.17%. With a float of $49.29 million, this company’s outstanding shares have now reached $93.26 million.
The firm has a total of 1102 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.15%, operating margin of 3.44%, and the pretax margin is 3.64%.
Enfusion Inc (ENFN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Software – Application Industry. The insider ownership of Enfusion Inc is 47.77%, while institutional ownership is 59.46%. The most recent insider transaction that took place on Jan 13 ’25, was worth 17,241. Before that another transaction happened on Jan 07 ’25, when Company’s Chief Executive Officer sold 2,771 for $10.13, making the entire transaction worth $28,070. This insider now owns 526,702 shares in total.
Enfusion Inc (ENFN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 62.17% per share during the next fiscal year.
Enfusion Inc (NYSE: ENFN) Trading Performance Indicators
Here are Enfusion Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.12. Likewise, its price to free cash flow for the trailing twelve months is 69.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.03, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.29 in one year’s time.
Technical Analysis of Enfusion Inc (ENFN)
Analysing the last 5-days average volume posted by the [Enfusion Inc, ENFN], we can find that recorded value of 1.55 million was better than the volume posted last year of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 52.55%. Additionally, its Average True Range was 0.46.
During the past 100 days, Enfusion Inc’s (ENFN) raw stochastic average was set at 83.74%, which indicates a significant increase from 75.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.83% in the past 14 days, which was higher than the 35.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.04, while its 200-day Moving Average is $9.19. Now, the first resistance to watch is $11.06. This is followed by the second major resistance level at $11.31. The third major resistance level sits at $11.71. If the price goes on to break the first support level at $10.40, it is likely to go to the next support level at $10.00. Should the price break the second support level, the third support level stands at $9.75.
Enfusion Inc (NYSE: ENFN) Key Stats
With a market capitalization of 1.39 billion, the company has a total of 128,571K Shares Outstanding. Currently, annual sales are 174,540 K while annual income is 6,030 K. The company’s previous quarter sales were 51,170 K while its latest quarter income was 1,420 K.
